ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,214.08
0.51%
US Tech 100
17,704.00
0.36%
다우존스 지수
39,387.76
0.85%
Bitcoin
62,855.83
-0.31%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Recursion Pharmaceuticals Inc (RXRX)

  7. Recursion Pharmaceuticals Inc (RXRX) 뉴스

RXRX

Recursion Pharmaceuticals (RXRX)

Recursion Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:RXRX
일자시간출처헤드라인심볼기업
2024/05/1005:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/05/1005:01GlobeNewswire Inc.Recursion Provides Business Updates and Reports First Quarter 2024 Financial ResultsNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/05/0221:00GlobeNewswire Inc.Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9NASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/05/0121:01GlobeNewswire Inc.Recursion to Participate in Upcoming Investor ConferencesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/04/3021:00GlobeNewswire Inc.Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering ProgramNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/04/1621:00GlobeNewswire Inc.Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial OfficerNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/04/0221:00GlobeNewswire Inc.Recursion to Participate in Upcoming Investor ConferenceNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/2621:00GlobeNewswire Inc.Recursion Publishes Annual Environmental, Social and Governance ReportNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/1117:00GlobeNewswire Inc.Recursion Announces Plans to Open New Office in LondonNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/0909:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/0808:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/0707:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/0706:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/0606:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/0204:58GlobeNewswire Inc.Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease CommunityNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/03/0121:59GlobeNewswire Inc.Recursion to Participate in Upcoming Investor ConferencesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/2922:25Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/2806:05GlobeNewswire Inc.Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/2409:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/2308:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/2207:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/2106:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/2021:59GlobeNewswire Inc.Recursion to Host Public L(earnings) Call on February 27NASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/1709:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/1709:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/1709:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/1608:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/1506:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/1409:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
2024/02/1409:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RXRXRecursion Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:RXRX

최근 히스토리

USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
AMEX
SPY
SPDR S&P 500
NASDAQ
AAPL
Apple
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
NYSE
AXP
American Express
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
BTCUSD
Bitcoin
NASDAQ
NVDA
NVIDIA
USOTC
ADDYY
Adidas (QX)
AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유